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Epi~ermal Langerhans cells (LC) undergo profound pheno-
tyPIC and functional alterations when cultured for 2 to 3 d. 
1'0 determine whether the in vitro culture of human LC 
rno~ulates their capacity to process and present intact protein 
antIgens, we compared the ability of freshly isolated LC 
(ftc) and cultured LC (cLC) to stimulate in vitro T-cell 
roliferative responses ' to recall antigens. We found that 
uI?an ftC and cLC were able to process and present recall 
antIgens to primed T cells, inducing significant proliferative 
responses. For tetanus toxoid and Candida albicans extract, 
T -cell proliferative responses at 6 d to antigen-pulsed ftC 
were slightly greater than responses to antigen-pulsed cLC. 
For live influenza A virus, the T-cell responses induced by 
antigen-pulsed cLC were comparable or slightly greater 
compared with ftc. Allogeneic T-cell proliferation for both 
LC preparations were also comparable. The exogenous path-
way of antigen processing was demonstrated by chloroquine 
inhibition. ] 1mlest Dermatol 99:331- 336, 1992 
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Epidermal Langerhans cells (LC) are very potent antigen-presenting cells (APC) of bone marrow origin [1] and normally comprise 2 - 5% of cells in mammalian epider-mis [2]. These cells initiate allogeneic T-cell prolifera-tion, antigen-specific T-cell activation, and cytotoxic 
T-cellproliferation [2-4]. LC playa critical role in both the afferent 
and efferent limbs of contact hypersensitivity reactions and skin-
graft rejection and may contribute to immunosurveillance against 
CUtaneous viral infections and neoplasia [5 - 7]. 
When murine LC are compared with other APC such as mono-
cyt~s/macrophages, several differences emerge. LC express class II 
tn~or histocompatibility complex (MHC) antigens constitutively, 
Whereas macrophages express these antigens facultatively [8,9]. 
Dunng short-term (2 to 3 d) culture, LC exhibit enhanced, and 
~onocytes progressively lose, surface expression of class II MHC 
ntlgens and accessory cell function [9 -11]. The effect of short-
terrn CUlture on LC has been most extensively studied in the mouse. 
0urine cultured LC (cLC) become markedly dendritic and acquire 
Increased surface expression of class II MHC antigens and ICAM-1 
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Abbreviations: 
APC: antigen-presenting cells 
CAND: Catldida albicallS extract 
EC: epidermal cells 
FACS: fluorescence-activated cell sorter 
FeR: Fc receptor 
FITC: fl uorescein isoth ioeyanate 
FLU: live influenza virus 
GM-CSF: granulocyte/macrophage colony-stimulating factor 
HLA: human leukocyte antigen 
KLH: keyhole limpet hemocyanin 
LC: Langerhans cells 
cLC: cultured Langerhans cells 
QC: freshly prepared Langerhans cells 
MHC: major histocompatibiliry complex 
PBMC: peripheral blood mononuclear cells 
TT: tetanus toxoid 
[10,12-14]. Concurrently, murine cLC lose or markedly reduce 
expression of ATPase [14], certain monocyte/macrophage markers, 
including nonspecific esterase, FcR, and F4/80 [14], and no longer 
exhibit their cytoplasmic (Birbeck) granules and endosomes [15]. 
Similar changes have been described in human cLC [16-18]. 
cLC are ten- to a hundredfold more potent than freshly prepared 
LC (fLC) in the induction of primary allogeneic or autologous 
T-cell proliferative responses, in the presentation of hap tens to anti-
gen-specific T-cell clones, and in the presentation of peptide anti-
gens to T-cell hybridomas [10,14,19,20]. In addition, cLC are more 
potent than fLC as accessory cells for CD3-driven T-cell prolifera-
tion, despite an apparent reduction of surface Fc receptors on LC 
after culture [21]. Of particular interest is the finding that murine 
fLC and cLC can each present antigen to previously primed (mem-
ory) T cells [19]' but only cLC are capable of initiating in vitro 
primary immune responses, i.e., the presentation of haptens or pep-
tide antigens to naive resting T cells [22]. In the human system, LC 
have demonstrated greater immunostimulatory capacity than mon-
ocytes in allogeneic T-cell activation [3,23], and cLC are more 
potent than fLC in both autologous and allogeneic T -cell activa-
tion, but only when cultured in the presence of exogenous GM-CSF 
[24]. 
The antigen-processing ability of cLC has been primarily studied 
in the mouse. Contradictory findings that cLC lost [15,25,26] or 
retained [10,22] the ability to process soluble protein antigens were 
clarified when inbred strains were compared, and it was found that 
the antigen-processing capacity of cLC is dependent on MHC hap-
lotype [27]. Human beings, however, represent an outbred popula-
tion without a consistent MHC haplotype. To address the question 
of the relative capacity of human cLC to process and present protein 
antigens, we compared the ability of fLC and 3-d cLC from epider-
mis of normal volunteers to stimulate T-cell proliferative responses 
to common recall protein antigens (tetanus toxoid, live influenza A 
virus, and Candida albicatzs extract). 
MATERIALS AND METHODS 
Preparation of Epidermal Cells Single cell suspensions of epi-
dermal cells (EC) were prepared from trypsinized suction blister 
roofs of normal volunteers, as previously described [28]. Briefly, 
suction blister roofs (epidermal sheets) were removed and floated in 
0.5% trypsin in phosphate-buffered saline for 45 min at 37 °C, 
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transferred to 0.05% DNAase in Hanks' balanced salt solution 
(HBSS), and disaggregated by repeated aspirations and expulsions of 
the epidermal sheets through a sterile syringe. Cells were filtered 
through a 100-flm nylon mesh, washed, suspended 1 X 106 cells/ 
ml in keratinocyte growth medium (Clonetics, San Diego, CAl 
supplemented with 200 U/ml recombinant human granulocyte/ 
macrophage colony-stimulating factor (GM-CSF) (Genzyme, Bos-
ton, MA), and plated in 24-well plates (Flow Laboratories, McLean, 
VA). EC were then utilized as freshly isolated EC (fEC) or were 
cultured for 72 h at 37°C in a humidified 5% CO2 atmosphere 
(cEC). 
Antigen-Pulsing of Epidermal Cells fEC or cEC were cul-
tured in the presence of a recall antigen for 18 h (antigen pulse). 
During this "pulsing" period, the fLC developed a dendritic mor-
phology, which facilitated their quantification by hemocytometer. 
The cLC that were "pulsed" maintained their dendritic morphol-
ogy during the 18-h pulse period. Live influenza A virus (FLU), 
tetanus toxoid (TT), and C. albicans extract (CAND) were used as 
recall antigens. FLU, as infectious allantoic fluid (gift of Dr. Gene 
Shearer), was used at a final concentration of 1: 100. TT (Con-
naught Laboratories, Willowdale, Ontario, Canada) was used at a 
fina l concentration of 40 Lf/ml. CAND (Hollister-Stier, Spokane, 
W A) was used at a final concentration of 1 : 30. 
Enrichment of Langer hans Cells Following the antigen pulse 
period, non-adherent EC were washed, resuspended in RPM I 1640 
with 10% human AB serum, layered over a Ficoll-sodium metri-
zoate density gradient (density 1.077) (Lymphoprep, Nycomed, 
Oslo, Norway), and centrifuged at 400 X g for 25 min. Typically,S 
to 20% of interface cells had dendritic morphology and stained 
positively with fluorescein isothiocyanate (FITC) -conjugated 
human leukocyte antigen (HLA)-DR (Becton-Dickinson, Moun-
tainview, CAl under fluorescent microscopy (data not shown). 
Enriched LC were irradiated (2000 rad, 137CS) and utilized for func-
tional studies. 
Preparation ofT Cells Autologous T cells were prepared from 
healthy epidermal cell donors. Peripheral blood mononuclear cells 
(PBMC) were obtained by centrifugation of heparinized whole 
blood over Lymphoprep at 600 X g for 15 min at 20 °C. Interface 
cells were incubated with 5 mM L-Ieucine methyl ester (Sigma) in 
serum-free RPMI 1640 for 1 h at room temperature [29]. The re-
sulting cells and cellular debris were centrifuged and reconstituted 
in complete medium, consisting of RPM I 1640 (Gibco, Grand Is-
land, NY) supplemented with 10% human AB serum (Sigma, St. 
Louis, MO) heat-inactivated for 60 minutes at 56 °C, 100 U/ml 
penicillin, 100 flg/ml streptomycin, 2 flg/ml fungizone (Gibco), 
2 mM L-glutamine (Gibco), 10 mM HEPES buffer solution 
(Gibco), 0.1 mM nonessential amino acids (Gibco), 1 mM sodium 
pyruvate (Gibco), 5 X 10-5 M 2-mercaptoethanol (Sigma), and 
1 flg/ml indomethacin (Sigma). This suspension was incubated for 
1 h in a nylon wool column at 37°C, and non-adherent cells were 
eluted [30]. 
T-Cell Proliferation Assay T-cell proliferative responses were 
measured by [3H]_ TdR incorporation, using a slight modification of 
a previously described technique [28]. For antigen-driven lympho-
cyte proliferation, as well as autologous and allogeneic epidermal 
cell-lymphocyte reactions, cells were cultured for 6 d in 96-well 
flat-bottom micro titer plates (Costar, Cambridge, MA) at 37°C, 
under a humidified 5% CO2 atmosphere. One microcurie of [3H]_ 
TdR (Amersham, Arlington Heights, IL) was added to each micro-
titer well during the last 15-18 h of culture. [3H]-TdR-labeled 
cells were harvested using a semi-automated cell harvester (PhD 
Cell Harvester, Cambridge Technology, Cambridge, MA), and 
[3H]_ TdR incorporation was measured by a liquid scintillation 
counter (Beckman, Fullerton, CAl. Responses were reported as 
mean cpm ± SEM from triplicate samples. 
Phytohemagglutinin T-Cell Stimulation Assay T cells (105/ 
well) were cultured for 3 d in the presence of 1 flg/ml phytohe-
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Figure 1. Time-dependent proliferative response ofT cells in the presence 
of antigen-pulsed LC. fLC were incubated with FLU for 18 h and then 
co-cultured with autologous T cells (lOS/well). T-cell proliferation was 
determined by measuring [3H)-TdR incorporation after 4 and 6 d of co-
culture. 
magglutinin (Burroughs-W ellcome, Research Triangle, N.C) ~n 
96-well flat-bottom micro titer plates. [3H]_ TdR was added 111 t e 
last 15 -18 h of culture and [3H]_ TdR uptake was measured. 
Staining and Flow-Cytometric Analysis Cells were was~ed 
and resuspended in Ca++ - and Mg++ -free HBSS with 1 % bO~1I1e 
serum albumin (Sigma), 0.01 % DNAase (Sigma), and 0.2% dls1i 
dium EDT A (Sigma), designated as fluorescence-activated ce 
sorter (FACS) buffer. Epidermal cells were stained with FITC-cond jugated anti - HLA-D R (class II MH C) or control FITC_conjugate 
IgG2a specific for keyhole limpet hemocyanin (KLH). (Becto~: 
Dickinson, Mountainview, CAl. T cells were stained With FIT Jl 
conjugated monoclonal antibodies Leu- l (CDS), HLA-DR (classC MHC), Leu-M3 (CD14), and Leu-12 (CD19) or control FIT -
conjugated IgGt and IgG2• specific for KLH (Becton-Dickinson). 
Stained cells were incubated for 30 min at 4 ° C, washed three wned 
resuspended in FACS buffer, transferred to polystyren~ t~bes, a)n 
analyzed by flow cytometry on a FACScan (Becton-Dlck1l1son . 
Inhibition of Antigen Processing by Chloroquine fEC a~d 
(S ' ) 'ror 3-d cEC were pretreated with 300 flM chloroquine Igrna t 
15 min to 1 h at 37° C, incubated with a recall antigen for 2 - 3 had 
3rC in the continued presence of chloroquine, and then washe 
free of chloroquine and antigen, as described [31]. These cells wer~ 
cultured an additional 18 h, enriched for LC, and co-cultured wltd 
T cells, as described above. Control experiments were perforrnhe 
wherein chloroquine was added to the cultures for 2 h after t 
antigens were cultured with the LC. 
Statistical Analysis p values were determined by the Student ~ 
test (two-tailed, paired) and considered statistically significant a 
p ,s; 0.01. 
RESULTS 
Kinetics of the T-Cell Recall Response When fLC ,!,e~e cu~~ 
tured with T cells for varying periods, we found that slgnlfica1). proliferative responses were detected by 6 d of co-culture (Fig ti-
When assayed on day 6, T-cell proliferation induced by both/ n II 
gen-pulsed fLC and cLC was consistently in a growth phase ror a 
antigens used (data not shown). 
'med Human cLC Process and Present Protein Antigens to Prl sS 
T Cells To determine whether cLC retained the ability to procere 
and present antigens, freshly prepared and 3-d cultured EC ;"se h, 
incubated with recall antigens (FLU, TT, or CAND) for . ra-
enriched for LC by centrifugation over a density gradient, x-Ir T 
diated, and co-cultured with accessory cell-depleted autologoUSul_ 
cells for 6 d. A constant number ofT cells (105 per well) was co-c 
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Figure 2. Processing and presentation of tetanus toxoid by freshly prepared 
and cultured human LC. Two representative experiments shown (A and B). 
TT-pulsed (40 Lf/ml) ftC orcLC were co-cultured for 6 d with 105 autolo-
~ous monocyte-depleted T cell s. T-cell proliferation was assessed by the 
Incorporation of [3HJ-TdR, which was added in the last 15 -18 h of co-
culture. 
tured with various numbers of LC, ranging from 800 per well to 
7500 per well. T-cell proliferation was assessed by [3H]_ TdR incor-
poration, added in the last 15-18 h of culture. For TT, freshly 
IsOlated_ and antigen-pulsed LC (ftC) and 3-d - cultured then 
p( ulsed LC (cLC) induced significant T-cell proliferation, in a dose-
nUmber of LC) dependent manner (Fig 2). The control autologous 
reaction showed a low background level of proliferation. In two 
representative experiments, ftC induced T -cell proliferative re-
sPOnses somewhat greater (36% and 22%, not statistically signifi-
cant) than cLC (Fig 2). CAND-pulsed LC also induced a significant 
proliferative response in a dose-dependent manner. In two repre-
sentative experiments, CAND-pulsed ftC induced proliferative re-
sponses again somewhat greater (33% and 15%, not statistically 
~gnificant) than CAND-pulsed cLC (Fig 3). In contrast to T! and 
AND, in most experiments, FLU-pulsed cLC induced slightly 
greater T-cell proliferative responses than FLU-pulsed ftc. In two 
repr.esentative experiments, FLU-pulsed cLC induced T-cell prolif-
~tatl.ve responses slightly greater (34% and 20%, not statistically 
gnlficant) than FLU-pulsed ftC (Fig 4) . cLC processed and 
presented recall antigens in 20 of 23 experiments. 
. In OUr system, ftc were antigen pulsed for 18 h, so that at the 
~Irne of co-cu lture with T cells these were effectively I-d cLC. t darly, 3-d cLC were antigen-pulsed for 18 h, so that at the time 
° co-cu lture these were effectively 4-d cLC. To address the possibil-
~ty that the presentation ability of 1-d cLC may differ from that of 
-d cLC, we compared the allostimulatory potency of these LC 
Preparations. We found that both 1-d cLC and 4-d cLC induced 
cO.rnparable T-cell proliferative responses (Fig 5). This is not sur-rISiI1g, as both of these cLC preparations exhibit markedly en-
/nced class II MHC expression. To confirm that T-cell prolifera-
IOn Was a consequence of antigen presentation by LC, we 
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Figure 3, Processing and presentation of C. albicatls extract by freshly pre-
pared and cultured LC. Two representative experiments shown (A and B). 
LC were exposed to C. albicallS extract (1 : 30) and assayed for antigen-pro-
cessing and -presenting ability, as described in Fig 2. 
demonstrated that no other functional antigen-presenting cells 
were present in co-cultures. The purified T-cell preparations were 
uniformly unresponsive to exogenous antigens (Figs 2 - 4) and phy-
tohemagglutinin (data not shown). The virtual absence of monocy-
tic cells and B cells within the T -cell preparation was demonstrated 
by flow cytometry, with 95%, 1.6%,0.3%, and 0.6% of cells posi-
tive for CDS (pan-T cell), HLA-DR (class II MHC), CD14 (mono-
cyte), and CD19 (B cell) (Becton-Dickinson), respectively (data not 
shown). 
The Exogenous Pathway of Antigen Processing is Utilized 
by LC To verify that human LC processed antigens by the exoge-
nous (acidic endosomal) pathway, we studied the antigen-process-
ing ability in the presence of chloroquine, a selective inhibitor of the 
exogenous pathway [32,33] . W e found that chloroquine regularly 
inhibited T-cell proliferation by antigen-pulsed ftC and cLC to an 
extent greater than the control allogeneic T-cell proliferation (Figs 
6 and 7) . Furthermore, when chloroquine was added to LC after 
antigen pulsing, there was no significant inhibition ofT-cell prolif-
eration (data not shown). Chloroquine inhibition of allogeneic pro-
liferation ranged from 7 to 56%. To determine whether the inhibi-
tory effects of chloroquine on antigen-driven or aIlogeneic T-cell 
proliferation were related to the surface expression of class II MHC 
or EC viability, we subjected fEC to a 4-h antigen pulse, a 4-h 
incubation with antigen plus chloroquine, or a 4-h sham treatment. 
Cells were then cultured for 18 h, and the entire non-adherent cell 
population was analyzed by flow cytometry for the expression of 
class II MHC (HLA-DR) antigens and for viability by propidium 
iodide staining. Each treatment yielded a comparable percentage of 
class II MHC bearing cells, comparable mean fluorescent intensity 
of class II MHC on LC, and comparable viability for both keratino-
cytes and LC (data not shown). 
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Figure 4. Processing and presentation of influenza A virus by freshly pre-
pared and cul~ured LC. Two representative experiments shown (A and B). 
LC were exposed to live influenza A virus (1 : 100) and assayed for antigen-
processing and -presenting ability. as described in Fig 2. 
DISCUSSION 
Murine and human LC undergo profound changes in phenotype 
and immunostimulatory function during short-term culture. Pheno-
typic changes include enhancement in the expression of the class II 
MHC antigens. with concomitant reduction or loss of Birbeck 
granules and acidic organelles (endosomes). as well as certain mon-
ocyte/macrophage markers. non-specific esterase. FcR. and the 
F4/80 antigen [10.12-16]. Although studies of the antigen-pro-
cessing ability of murine cLC had yielded contradictory data 
[10.15.22.25.26]. it appears that the retention or loss of antigen 
processing in murine cLC is MHC-dependent [27]. Despite the 
down-regulation of acidic organelles and Birbeck granules in cLC 
in both the mouse and human [15.16]. data from the murine system 
and the data obtained in the current study of human LC demonstrate 
that antigen-processing ability is a property of both fLC and cLC. 
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Figure 5. Time course of allogeneic T-cell response. using 1-d and 4-d cLC 
as stimulators. Open circles. T cells plus 4-d cLC. Closed circles, T cells plus 1-d 
cLC. Opetl squares, T cells alone. 
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Figure 6. Effects of chloroquine on antigen processing of FLU by fLC on 
alloantigen presentation. In the presence of chloroquine. there was an 8~% 
decrease in the ability of fLC to induce antigen-specific T -cell proliferatIOn 
(A), compared with a 26% decrease in alloantigen-induced T-cell prolifera-
tion (B) . 
We found that the ability of human -LC to process and present 
native antigens to primed T cells is retained after 3 d of culture .. In 
general. differences between the antigen-processing/present1l11 
ability of fLC and cLC were most apparent. at higher numbers 0 
stimulator cells. For both CAND and TT. we found that antlg<:n-
pulsed fLC consistently induced slightly greater T-cell proliferative 
responses than antigen-pulsed cLC. These findings contrast sorne-
what with those ofTeunissen et al [18]' who recently reported that 
cLC were "consistently better stimulator cells" than fLC. The read 
son for the varied findings may be accounted for by the method used 
for the preparation of their fLC. Teunissen et al positively selecte 
fLC using a panning technique with OKT6 and antimouse lrnrn~­
noglobulin. Furthermore. GM-CSF was not added to any of th~lr 
cultures [18]. Their T-cell responses when fLC were used were ~ 
the order of 3.000-8.000 cpm and 5.000-18.000 cpm to CAN 
and TT. respectively [18]. Our findings differed considerably in that 
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Figure 7. Effects of chloroquine on antigen processing of FLU by cL~5~2 
alloantigen presentation. In the presence of chloroquine. there was an 'on 
decrease in the ability of cLC to induce antigen-specific T-cell prolifera~lra_ 
(A), compared with a 56% decrease in alloantigen-induced T-cell pro 1 e 
tion (B). 
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Optimal numbers of fLC induced 47,000-100,000 cpm and 
30,000-85,000 cpm to CAND and TT, respectively. Notwith-
standing these differences, both studies demonstrate that both fLc 
and cLC can process and present exogenous protein antigens. 
Viral antigens are usually presented by the endogenous pathway, 
w[ hlCh is chloroquine resistant [34]; however, there are exceptions 
35], such as FLU, which is presented by the exogenous pathway 
[35] .. Live FLU-pulsed cLC induced comparable or greater T-cell 
prohferative responses than did fLe. Because the end-point of our 
assay was T-cell proliferation, in which the direct measurement of 
antigen processing independent of presentation was not possible, 
more specific inferences about the antigen-processing machinery of 
ftc versus cLC cannot be made. The general scheme of the exoge-
~ous (MHC class II) pathway of antigen processing and presenta-
tion can be summarized: 1) endocytosis of the antigen; 2) proteolysis 
Within acidic endosomes; 3) transport to the endosomes of class II 
~HC, either newly synthesized or recycled from the cell surface; 4) 
rescue" of antigenic peptides from further degradation by binding 
to class II MHC within endosomes, with concomitant stabilization 
of class II-antigen complex; and 5) transport of the class II - antigen 
cOmplex to the cell surface for presentation. Thus, measurement of 
theT -cell response gives no indication of the number of class II-
antigen complexes necessary to produce such a response [36,37]. It is 
Pos.slble that fLC and cLC may have utilized different pathways of 
antigen processing, e.g., a different repertoire of endosomal pro-
teases, yielding different or the same epitopes [38 - 40]. This latter 
POl!1t cannot be determined in our studies, as peripheral blood T 
ceUs rather than T-cell clones were used as responder cells. 
~hloroquine is a specific inhibitor of the exogenous pathway of 
antigen processing [32,33]. We found that the processing of each 
recaU antigen in both fLC and 3-d cLC was inhibited by chloro-
QUl!1e, indicating that the exogenous pathway of antigen processing 
;as required. However, chloroquine consistently induce~ a lesser 
egree of inhibition (from 7 to 56%) of control allogeneic T-cell 
proliferation. This is in keeping with recent data that indicate that 
chloroquine specifically inhibits allorecognition when fLC are used 
as stimulators [41]. Chloroquine inhibits the dissociation of the 
hnvariant chain from the class II heterodimer in both the murine and 
buman system [32,42] and has been shown to slightly decrease the 
hlosynthesis of class II in mice [42]. Our flow-cytometric analysis, 
t owever, showed no change in the surface expression ofHLA-DR 
Or EC treated with chloroquine. In addition, chloroquine treat-
ment did not alter the viability of EC or the HLA-DR-positive 
£ubset, suggesting that chloroquine did not exert its inhibitory ef-
ects on allogeneic T-cell proliferation by direct toxicity to Ee. 
The possibility of collaboration between LC and other accessory 
celis [43,44] made the elimination of accessory cells from the T-cell 
prep~ration particularly important. The abrogation of accessory cell 
~CtIVI.ty in the T-cell preparation was consistently demonstrated in 
aUn~t.lOnal assays, and the depletion of monocytes and B cells was 
ddUlOnally confirmed by flow cytometry in several experiments. 
. I~ the murine system, dendritic cells have the unique property of 
Initiating primary immune responses. Murine cLC have been used 
hn Vitro to induce primary sensitization of naive resting T cells to 
aptens and peptide antigens [22]. In the human system as well, the 
Stimulation of resting T cells appears to be restricted to dendritic helis [45]. The goal of our future studies is to determine whether 
Uman cLC can induce primary in vitro sensitization and thus gener-
ate antigen-specific T cells that respond to viral or tumor antigens. 
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